Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opko Health Inc (OPK)
NASDAQ:OPK
Opko Health (OPK) Stock Price & Analysis
3,004 Followers
OPK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.85 - $2.18
Previous Close$1.49
Volume4.11M
Average Volume (3M)3.66M
Market Cap
$1.04B
Enterprise Value$1.25B
Total Cash (Recent Filing)$95.88M
Total Debt (Recent Filing)$308.75M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Aug 01, 2024EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding696,991,677
10 Day Avg. Volume3,354,484
30 Day Avg. Volume3,662,523
Standard Deviation0.22
R-Squared0.18
Alpha-0.00460
Financial Highlights & Ratios
Price to Book (P/B)-5.89
Price to Sales (P/S)0.98
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.45
Enterprise Value/Gross Profit3.93
Enterprise Value/Ebitda-18.19
Forecast
1Y Price Target
$2.50Price Target Upside67.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Opko Health News
PremiumCompany Announcements
Opko Health Secures $250M in Notes, Eyes Expansion
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst's recommendation: reiterate Buy rating and $3 price target.
Divestiture AgreementOPKO announced an agreement to divest around $100 million in annual BRL revenue to Labcorp.
Strategic TransactionThe company is slated to receive $237.5M from the Labcorp transaction.
Bears Say
Financial PerformanceOPKO’s first quarter financial results fell short both in terms of top-line performance and EPS relative to analyst modeling as well as consensus.
Revenue ExpectationsNGENLA revenue came in lighter than both analyst and company expectations.
Total RevenueConsolidated total revenues were $173.7M, representing a 27% YoY decline and missing analyst projection of $180.0M.
---
Ownership Overview
67.13% Insiders
7.06% Mutual Funds
8.40% Other Institutional Investors
17.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OPK FAQ
What was Opko Health Inc’s price range in the past 12 months?
Opko Health Inc lowest stock price was $0.85 and its highest was $2.17 in the past 12 months.
What is Opko Health Inc’s market cap?
Currently, no data Available
When is Opko Health Inc’s upcoming earnings report date?
Opko Health Inc’s upcoming earnings report date is Aug 01, 2024 which is in 10 days.
How were Opko Health Inc’s earnings last quarter?
Opko Health Inc released its earnings results on May 07, 2024. The company reported -$0.12 earnings per share for the quarter, missing the consensus estimate of -$0.095 by -$0.025.
Is Opko Health Inc overvalued?
According to Wall Street analysts Opko Health Inc’s price is currently Undervalued.
Does Opko Health Inc pay dividends?
Opko Health Inc does not currently pay dividends.
What is Opko Health Inc’s EPS estimate?
Opko Health Inc’s EPS estimate is -$0.1.
How many shares outstanding does Opko Health Inc have?
Opko Health Inc has 696,991,700 shares outstanding.
What happened to Opko Health Inc’s price movement after its last earnings report?
Opko Health Inc reported an EPS of -$0.12 in its last earnings report, missing expectations of -$0.095. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Opko Health Inc?
Among the largest hedge funds holding Opko Health Inc’s share is Gamco Investors, Inc. ET AL. It holds Opko Health Inc’s shares valued at 216K.
---
Opko Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2.50 (67.79% Upside)
$2.50 (67.79% Upside)
Blogger Sentiment
Bullish
OPK Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 291.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $335.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 2.3%
Last 30 Days ▲ 2.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.69%
12-Months-Change
Fundamentals
Return on Equity
-18.00%
Trailing 12-Months
Asset Growth
-9.02%
Trailing 12-Months
Company Description
Opko Health Inc
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
---
OPK Earnings Call
Q1 2024
0:00 / 0:00
---
OPK Stock 12 Month Forecast
Average Price Target
$2.50
▲(67.79% Upside)
Technical Analysis
Best Analysts Covering OPK
1 Year
1 Year Success Rate
14/35 ratings generated profit
1 Year Average Return
+11.00%
reiterated a buy rating 3 months ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +11.00% per trade.
---